Company intelligence / Profile preview

personalEYES

Australia

Ownership: Private
Employees: ~65
Development stage: Other

Overview

personalEYES provides advanced clinical ophthalmic care, including refractive and cataract surgeries, and participates in multi-center and international clinical studies with device and pharmaceutical partners. The company routinely employs new technologies for improved safety and visual outcomes, and some research collaborations reach as far as Phase 1 clinical trials in partnership with global healthcare companies.

Therapeutic areas: Ophthalmology
Modalities: DeviceNon-pharmacological therapy
Industry: Non-Academic Healthcare

Partnerships

Johnson & Johnson Surgical VisionAlcon Research LtdOculentisONL TherapeuticsNacuity PharmaceuticalsGlaxoSmithKline Research & Development Limited

Beyond the preview

Go deeper on personalEYES.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on personalEYES.

Explore the full profile